caulfield hospital
Alfred Respiratory Medicine has a long and internationally recognised track record in clinical trials. Across a wide range of respiratory conditions, including rare and advanced diseases, we have helped establish novel drug therapies, devices and behavioural treatments. We are a leader in early and late phase clinical trials and implementation studies. We led and completed many investigator-initiated studies, as well as being leading co-investigators in large international multi-centre studies.
We need clinical trials to prove that a new medication, device or treatment is safe and effective for people.
Without clinical trials, new treatments and medicines cannot be approved for use in Australia.
Our program trials new respiratory treatments across the entire research pipeline, and is the only Australian program that can provide a comprehensive bench-to-bed drug discovery pathway on one site including:
Our clinical trials capacity is enhanced by:
Find out more about our Respiratory Medicine research.
There are four different phases of a clinical trial. Each phase is represented by a roman numeral.
We conduct clinical trials of new treatments for respiratory disorders including:
The Respiratory Medicine department, led by Prof Trevor Williams has extensive leadership experience in leading clinical trials.
Our clinical trial leads are:
ClinTrial Refer is a quick way to see all of our open trials, in one place. It’s the easy way to find a trial that may be right for you or your patient.
Spring marks the start of thunderstorm asthma season (1 September – 31 December) and doctors at the Alfred Hospital are urging people to start taking preventative measures, even if they have not suffered from asthma before.